uniQure QURE Hemgenix — Supplies Expense

Similar metrics at other companies

FMBHSupplies Expense

$311K-15.3%

BOTJMortgage — Supplies Expense

$4K0.0%

GSBCBanking — Supplies Expense

$222K-16.5%

LHDiagnostics — Supplies Expense

$613.5M+4.6%

BOTJCommunity Banking — Supplies Expense

$148K+13.8%

WSBCCommunity Banking — Supplies Expense

$2.01M+19.2%

FAQ

What is uniQure's hemgenix — supplies expense?

uniQure (QURE) reported hemgenix — supplies expense of $1.56M in Q4 2025.

How has uniQure's hemgenix — supplies expense changed year-over-year?

uniQure's hemgenix — supplies expense increased by 94.4% year-over-year, from $803.75K to $1.56M.

What does hemgenix — supplies expense mean?

This metric represents the direct costs associated with the procurement of raw materials, specialized reagents, and consumables required for the manufacturing and distribution of the Hemgenix gene therapy product. It reflects the variable production overhead necessary to maintain supply chain continuity for commercialized therapeutic treatments. Monitoring this expense helps assess the scalability and direct cost-of-goods-sold efficiency of the company's primary commercial asset.